Avash Das
@avash22.bsky.social
MGP Fellow @MGBpathology @harvardmed|PhD @lab_hobbs @UTSW via @SaumyaDas_lab|
Taking T-Acute Lymphoblastic Leukemia (T-ALL) a ‘NOTCH’ higher (1/n): #AMPtutorials #AMPath24 #molpath
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
August 17, 2025 at 2:28 PM
Taking T-Acute Lymphoblastic Leukemia (T-ALL) a ‘NOTCH’ higher (1/n): #AMPtutorials #AMPath24 #molpath
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.